Post‑transplant recurrent pericarditis with pericardial tamponade is successfully treated with colchicine: A case report

Gao,Chen; Peng,Fenghua; Peng,Longkai

doi:10.3892/etm.2014.1824

Post‑transplant recurrent pericarditis with pericardial tamponade is successfully treated with colchicine: A case report

Authors:
- Chen Gao
- Fenghua Peng
- Longkai Peng
View Affiliations

Affiliations: Department of Urological Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China
Published online on: July 4, 2014 https://doi.org/10.3892/etm.2014.1824
Pages: 801-804

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recurrent pericarditis is a rare complication following renal transplantation. Colchicine, an inhibitor of microtubule polymerization, has been recommended for the treatment of recurrent acute pericarditis in non‑transplant patients and is commonly used for the treatment of gout in transplant patients. However, the use of colchicine for the treatment of recurrent pericarditis in renal transplant patients has rarely been reported. In the present study, a rare case of recurrent pericarditis, manifested as large pericardial effusion and pericardial tamponade within the first year following renal transplantation, was successfully treated with colchicine. Therefore, low‑dose colchicine may be a safe and effective option for the treatment of recurrent pericarditis in renal transplant patients.

View Figures

View References

1	Sever MS, Steinmuller DR, Hayes JM, Streem SB and Novick AC: Pericarditis following renal transplantation. Transplantation. 51:1229–1232. 1991. View Article : Google Scholar : PubMed/NCBI
2	Alpert MA and Ravenscraft MD: Pericardial involvement in end-stage renal disease. Am J Med Sci. 325:228–236. 2003. View Article : Google Scholar : PubMed/NCBI
3	Maisch B, Seferović PM, Ristić AD, et al; Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 25:587–610. 2004. View Article : Google Scholar : PubMed/NCBI
4	Mayosi BM, Burgess LJ and Doubell AF: Tuberculous pericarditis. Circulation. 112:3608–3616. 2005. View Article : Google Scholar : PubMed/NCBI
5	Bertrand D, Desbuissons G, Pallet N, et al: Sirolimus therapy may cause cardiac tamponade. Transpl Int. 26:e4–e7. 2013. View Article : Google Scholar : PubMed/NCBI
6	Maisch B: Recurrent pericarditis: mysterious or not so mysterious? Eur Heart J. 26:631–633. 2005. View Article : Google Scholar : PubMed/NCBI
7	Gianni F and Solbiati M; Gruppo di Autoformazione Metodologica (GrAM). Colchicine is safe and effective for secondary prevention of recurrent pericarditis. Intern Emerg Med. 7:181–182. 2012. View Article : Google Scholar : PubMed/NCBI
8	Markel G, Imazio M, Brucato A and Adler Y: Prevention of recurrent pericarditis with colchicine in 2012. Clin Cardiol. 36:125–128. 2013. View Article : Google Scholar : PubMed/NCBI
9	Imazio M, Brucato A, Cemin R, et al; CORP (COlchicine for Recurrent Pericarditis) Investigators. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 155:409–414. 2011. View Article : Google Scholar : PubMed/NCBI
10	Imazio M, Bobbio M, Cecchi E, et al: Colchicine as first-choice therapy for recurrent pericarditis: Results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 165:1987–1991. 2005. View Article : Google Scholar : PubMed/NCBI
11	Imazio M, Spodick DH, Brucato A, Trinchero R and Adler Y: Controversial issues in the management of pericardial diseases. Circulation. 121:916–928. 2010. View Article : Google Scholar : PubMed/NCBI
12	Artom G, Koren-Morag N, Spodick DH, et al: Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J. 26:723–727. 2005. View Article : Google Scholar : PubMed/NCBI
13	Bouquié R, Deslandes G, Renaud C, et al: Colchicine-induced rhabdomyolysis in a heart/lung transplant patient with concurrent use of cyclosporin, pravastatin, and azithromycin. J Clin Rheumatol. 17:28–30. 2011.PubMed/NCBI
14	Garrouste C, Philipponnet C, Kaysi S, et al: Severe colchicine intoxication in a renal transplant recipient on cyclosporine. Transplant Proc. 44:2851–2852. 2012. View Article : Google Scholar : PubMed/NCBI
15	Llaudó I, Colom H, Giménez-Bonafé P, et al: Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study. Transpl Int. 26:177–186. 2013.